Biosensor research expands globally to reach a variety of key industries

SAN ANTONIO--October 31, 2002-- Since the terrorist attacks on September 11, 2001, and the anthrax mailings in their wake, military, law enforcement, and security agencies have focused on using biosensors to detect biological and chemical agents.

Universities conduct the majority of biosensor research, most often with government support, which has risen since 9/11. Private companies provide the third pillar in the biosensor alliance, commercializing and marketing these devices that measure biological phenomena.

Biosensors are made on the molecular scale, making nanotechnology a key ingredient in creating and adapting them. The international scope of biosensing includes systems in development and commercially available technologies from Europe, Israel, North America and the Pacific Rim.

"Researchers continue to exploit the potential of biosensors in speeding new drug trials, monitoring and regulating time released medication, and detecting toxic agents and explosives that are the deadliest weapons in terrorism's and rogue states' arsenals," says Technical Insights Analyst Michael Valenti.

Because biosensors are costly devices, many companies and universities, and their researchers are seeking ways to make them more economical. For example, molecular imprinted polymers may soon be used as the recognition element within biosensors.

"These polymers provide the high physical and chemical stability needed to work with immobilized biomaterials such as enzymes and antibodies in a biosensing role," says Valenti. "Further, when the target molecule has no biomaterial available as the recognition component, the imprinted polymer provides an excellent, and often the only, solution."

Other biosensor developers are using a biomimic technique to fashion polymers. This involves using modular polymer scaffolds that are programmed to attract building block molecules. Chemical interactions cause these components to self-assemble into

Contact: Julia Rowell
Technical Insights

Page: 1 2 3

Related biology news :

1. Biosensor-regulated gene therapy reduces heart attack damage in mice
2. Biosensor expected to improve food safety
3. Biosensor Is A Model For Widespread Testing Of Chemicals, Molecules
4. Leader in cancer treatment and prevention research honored
5. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
6. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
7. Belgian researchers explore revolutionary approach to angiogenesis
8. Award winning researchers reveal potential new role for Glivec
9. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
10. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
11. Gene chips research in cotton could lead to superior variety

Post Your Comments:

(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: